Search

everythinglearnresearchcommunity

for

Search:↓

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Narrowband Ultraviolet B treatment can significantly reduce anxiety in psoriasis patients, but it doesn't significantly affect depression.

Androgenetic alopecia significantly affects mental health and quality of life, highlighting the need for psychiatric evaluations.

Women with PCOS tend to have higher anxiety and depression levels compared to healthy women.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

Women with PCOS are much more likely to experience depression.

Healthcare workers in Turkey experienced more skin problems due to frequent handwashing and wearing masks and gloves during the COVID-19 outbreak.

Women with PCOS often experience anxiety, depression, and a lower quality of life.

People with polycystic ovary syndrome often experience anxiety and depression.

Baricitinib improves quality of life and reduces anxiety and depression in severe alopecia areata patients with hair regrowth.

Many people with alopecia experience high levels of social anxiety, anxiety, and depression, and while wigs can boost confidence, they may also cause anxiety.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Hair loss severity is linked to depression, not anxiety, in Filipino men, with older, less educated men with more hair loss at higher risk.

Finasteride may cause slight depression and anxiety.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Hair loss can cause anxiety and depression, especially in young, single women, and early psychological support is important.

People with hair loss conditions experience more anxiety, depression, and a lower quality of life than those without these conditions.

People with alopecia often feel anxious, depressed, and have low self-esteem.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

Finasteride may increase suicide risk; more research needed.

Regrowing scalp hair improves quality of life and reduces anxiety and depression in severe alopecia areata patients.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Lupus patients' body image issues significantly affect their mental health and need more support.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Japanese patients and physicians often disagree on the severity of Alopecia Areata and treatment satisfaction, needing better communication and treatments.

Skin diseases can cause psychological issues, and better integration of dermatology and psychiatry is needed to improve patient care.

Alopecia areata severely impacts quality of life, mental health, and work productivity.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.